Advertisement

Drugs & Therapy Perspectives

, Volume 9, Issue 5, pp 5–7 | Cite as

Conventional therapy still the mainstay for myocarditis

New Drugs and Therapeutics

Keywords

Acute Myocardial Infarction Myocarditis Kawasaki Disease Streptokinase Viral Myocarditis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wilson JD, et al., editors. Harrison’ s principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994: 1093–4Google Scholar
  2. 2.
    Caforio ALP, McKenna WJ. Recognition and optimum management of myocarditis. Drugs 1996 Oct; 52(4): 515–25PubMedCrossRefGoogle Scholar
  3. 3.
    Laws Houghton J. Pericarditis and myocarditis. Which is benign and which isn’ t? Postgrad Med 1992 Feb 1; 91: 273–82Google Scholar
  4. 4.
    Aretz HT, Billingham ME, Edwards WE, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiol Pathol 1985; 1: 1–10Google Scholar
  5. 5.
    Mason JW, O’Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269–75PubMedCrossRefGoogle Scholar
  6. 6.
    Williams JF, Bristow MR, Fowler MB, et al. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 1995; 92: 2764–84CrossRefGoogle Scholar
  7. 7.
    Drucker NA, Colan SD, Lewis AB, et al. γ-Globulin treatment of acute myocarditis in the pediatric population. Circulation 1994; 89: 252–7PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1997

Personalised recommendations